Pharsight

Schering patents expiration

1. Noxafil patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8263600 SCHERING Antifungal composition with enhanced bioavailability
Apr, 2022

(1 year, 5 months ago)

Drugs and Companies using POSACONAZOLE ingredient

Market Authorisation Date: 15 September, 2006

Treatment: NA

Dosage: SUSPENSION;ORAL

How can I launch a generic of NOXAFIL before it's drug patent expiration?
More Information on Dosage

NOXAFIL family patents

Family Patents

2. Rebetol patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6790837 SCHERING Ribavirin syrup formulations
Apr, 2023

(5 months ago)

US6790837

(Pediatric)

SCHERING Ribavirin syrup formulations
Oct, 2023

(10 days from now)

Drugs and Companies using RIBAVIRIN ingredient

Market Authorisation Date: 29 July, 2003

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

REBETOL family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic